パイプカットの世界市場：薬剤、タイプ、患者、エンドユーザー別-2025-2030年予測

パイプカット市場は、2023年に196億3,000万米ドルと評価され、2024年には211億6,000万米ドルに達すると予測され、CAGR 7.89％で成長し、2030年には334億1,000万米ドルになると予測されています。

パイプカット、男性の不妊手術のための外科的手順は、精子が射精に入るのを防ぐために精管を切断または封鎖することです。パイプカットの必要性は、永久的な避妊法としての有効性から生じ、家族計画に確実な解決策を提供します。この手術は主に、長期的な避妊方法を求める男性に適用されます。最終用途の範囲には、パイプカットが行われるクリニック、病院、外来手術センターなどのヘルスケア施設が含まれます。パイプカット市場は、男性避妊法の選択肢に対する意識の高まり、効果的で永続的な避妊法に対する需要の高まり、家族計画における責任の共有の重視の高まりなど、いくつかの影響要因により拡大しています。さらに、低侵襲手術技術の進歩により手術の安全性が向上し、受容率や採用率が高まる可能性があります。認知度やアクセスがまだ低い新興市場にも潜在的な機会は存在し、教育やサービス拡大のチャンスとなります。費用対効果が高く、侵襲性の低い手技を開拓することで、躊躇している層の注目を集め、市場への浸透を高めることもできると思われます。しかし、文化的抵抗、地域によっては認知度の低さ、手技に関する誤解といった限界は、市場成長の課題となりうる。最も重要な技術革新は、回復時間や不快感を最小化するための手技の強化や、男性の避妊法への関与を非宗教化するための教育的働きかけの強化にあります。もう一つの潜在的な研究分野は、患者に与えるパイプカットの心理的影響です。パイプカット市場の性質は、より多くの男性が家族計画への包括的なアプローチの一部としてパイプカットの利点を認識するにつれて、徐々に受容を拡大する方向にシフトしています。教育キャンペーンや技術の進歩に投資する企業は、この拡大する分野で競争優位に立つことができます。

市場力学：急速に進化するパイプカット市場の主要市場インサイトを公開

パイプカット市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • パイプカットに関する認知を促進する政府のイニシアティブの高まり
  • 男性不妊手術に関する認知を高める政府の取り組み
• 市場抑制要因
  • パイプカット手術に伴うリスク
• 市場機会
  • 技術進歩に伴う研究開発活動への投資の増加
• 市場の課題
  • 発展途上地域における認知度の低さと社会的タブー

ポーターの5つの力：パイプカット市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、パイプカット市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：パイプカット市場における外部からの影響の把握

外部マクロ環境要因は、パイプカット市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析パイプカット市場における競合情勢の把握

パイプカット市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスパイプカット市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、パイプカット市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨パイプカット市場における成功への道筋を描く

パイプカット市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • パイプカットに関する意識を高めるための政府の取り組みの高まり
    • 男性不妊手術に関する意識を高める政府の取り組み
  • 抑制要因
    • パイプカット手術に伴うリスク
  • 機会
    • 技術の進歩とともに研究開発活動を促進するための投資の増加
  • 課題
    • 発展途上地域における認識の低さと社会的タブー
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 パイプカット市場薬物別

• 麻酔薬
• 抗生物質
• 鎮痛剤

第7章 パイプカット市場：タイプ別

• 従来型
• 低侵襲
• メスなし

第8章 パイプカット市場患者別

• 動物
• 人間

第9章 パイプカット市場：エンドユーザー別

• 病院・クリニック
• 調査と学術

第10章 南北アメリカのパイプカット市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のパイプカット市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのパイプカット市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Accurate Surgical & Scientific Instruments Corporation
• Advanced Meditech International
• Bayer AG
• Bristol Myers Squibb Company
• Eli Lilly and Company
• GlaxoSmithKline plc
• Kapp Surgical Instrument Inc.
• McKesson Medical-Surgical Inc.
• Novartis AG
• PARAGON MEDICAL SUPPLY, INC.
• Pfizer, Inc.
• Sanofi S.A.
• Sklar Surgical Instruments
• Surtex Instruments Limited
• Wexler Surgical, Inc.

LIST OF FIGURES

• FIGURE 1. VASECTOMY MARKET RESEARCH PROCESS
• FIGURE 2. VASECTOMY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VASECTOMY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VASECTOMY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VASECTOMY MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VASECTOMY MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VASECTOMY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VASECTOMY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VASECTOMY MARKET SIZE, BY PATIENT, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VASECTOMY MARKET SIZE, BY PATIENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VASECTOMY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VASECTOMY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES VASECTOMY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES VASECTOMY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. VASECTOMY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. VASECTOMY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VASECTOMY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VASECTOMY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VASECTOMY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VASECTOMY MARKET DYNAMICS
• TABLE 7. GLOBAL VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VASECTOMY MARKET SIZE, BY ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VASECTOMY MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VASECTOMY MARKET SIZE, BY PAINKILLERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VASECTOMY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VASECTOMY MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VASECTOMY MARKET SIZE, BY NO-SCALPEL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VASECTOMY MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VASECTOMY MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VASECTOMY MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VASECTOMY MARKET SIZE, BY RESEARCH & ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CANADA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 35. CANADA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 37. CANADA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES VASECTOMY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CHINA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 57. CHINA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 59. CHINA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. INDIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 61. INDIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 63. INDIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA VASECTOMY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ITALY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 130. ITALY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 132. ITALY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. POLAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 146. POLAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 148. POLAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. QATAR VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 150. QATAR VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 152. QATAR VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM VASECTOMY MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM VASECTOMY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM VASECTOMY MARKET SIZE, BY PATIENT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM VASECTOMY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. VASECTOMY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 190. VASECTOMY MARKET, FPNV POSITIONING MATRIX, 2023

The Vasectomy Market was valued at USD 19.63 billion in 2023, expected to reach USD 21.16 billion in 2024, and is projected to grow at a CAGR of 7.89%, to USD 33.41 billion by 2030.

Vasectomy, a surgical procedure for male sterilization, involves cutting or sealing the vas deferens to prevent sperm from entering the ejaculate. The necessity of vasectomies arises from their effectiveness as a permanent form of contraception, providing a reliable solution for family planning. This procedure primarily finds application in men seeking long-term birth control solutions. The end-use scope encompasses healthcare facilities, including clinics, hospitals, and outpatient surgical centers, where vasectomies are performed. The market for vasectomy is expanding due to several influencing factors: increasing awareness about male contraceptive options, rising demand for effective and permanent birth control methods, and the growing emphasis on shared responsibility in family planning. Additionally, advancements in minimally invasive surgical techniques have improved the procedure's safety, potentially boosting acceptance and adoption rates. Potential opportunities exist in emerging markets where awareness and access remain lower, offering a chance to educate and expand services. Developing cost-effective, less invasive procedures may also capture the attention of hesitant demographics, enhancing market penetration. However, limitations such as cultural resistance, limited awareness in some regions, and misconceptions about the procedure can pose challenges to market growth. The most significant innovations lie in enhancing procedural techniques to minimize recovery time and discomfort, as well as increasing educational outreach to destigmatize male involvement in contraceptive methods. Another potential area of research is the psychological impact of vasectomy on patients, which can address concerns and improve satisfaction post-procedure. The nature of the vasectomy market is gradually shifting towards increasing acceptance as more men recognize its benefits as part of a comprehensive approach to family planning. Companies that invest in educational campaigns and technological advancements stand to gain a competitive edge in this expanding field.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vasectomy Market

The Vasectomy Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising government initiatives to promote awareness about the vasectomy
  • Government initiatives raising awareness about male sterilization
• Market Restraints
  • Risk associated with vasectomy surgeries
• Market Opportunities
  • Increased investments to boost the research and development activities along with technological advancement
• Market Challenges
  • Limited awareness and social taboo in developing regions

Porter's Five Forces: A Strategic Tool for Navigating the Vasectomy Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vasectomy Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vasectomy Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vasectomy Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vasectomy Market

A detailed market share analysis in the Vasectomy Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vasectomy Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vasectomy Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vasectomy Market

A strategic analysis of the Vasectomy Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vasectomy Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accurate Surgical & Scientific Instruments Corporation, Advanced Meditech International, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Kapp Surgical Instrument Inc., McKesson Medical-Surgical Inc., Novartis AG, PARAGON MEDICAL SUPPLY, INC., Pfizer, Inc., Sanofi S.A., Sklar Surgical Instruments, Surtex Instruments Limited, and Wexler Surgical, Inc..

Market Segmentation & Coverage

This research report categorizes the Vasectomy Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug, market is studied across Anesthetics, Antibiotics, and Painkillers.
• Based on Type, market is studied across Conventional, Minimally Invasive, and No-Scalpel.
• Based on Patient, market is studied across Animal and Human.
• Based on End-User, market is studied across Hospital & Clinic and Research & Academic.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising government initiatives to promote awareness about the vasectomy
    • 5.1.1.2. Government initiatives raising awareness about male sterilization
  • 5.1.2. Restraints
    • 5.1.2.1. Risk associated with vasectomy surgeries
  • 5.1.3. Opportunities
    • 5.1.3.1. Increased investments to boost the research and development activities along with technological advancement
  • 5.1.4. Challenges
    • 5.1.4.1. Limited awareness and social taboo in developing regions
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vasectomy Market, by Drug

• 6.1. Introduction
• 6.2. Anesthetics
• 6.3. Antibiotics
• 6.4. Painkillers

7. Vasectomy Market, by Type

• 7.1. Introduction
• 7.2. Conventional
• 7.3. Minimally Invasive
• 7.4. No-Scalpel

8. Vasectomy Market, by Patient

• 8.1. Introduction
• 8.2. Animal
• 8.3. Human

9. Vasectomy Market, by End-User

• 9.1. Introduction
• 9.2. Hospital & Clinic
• 9.3. Research & Academic

10. Americas Vasectomy Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Vasectomy Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Vasectomy Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Accurate Surgical & Scientific Instruments Corporation
• 3. Advanced Meditech International
• 4. Bayer AG
• 5. Bristol Myers Squibb Company
• 6. Eli Lilly and Company
• 7. GlaxoSmithKline plc
• 8. Kapp Surgical Instrument Inc.
• 9. McKesson Medical-Surgical Inc.
• 10. Novartis AG
• 11. PARAGON MEDICAL SUPPLY, INC.
• 12. Pfizer, Inc.
• 13. Sanofi S.A.
• 14. Sklar Surgical Instruments
• 15. Surtex Instruments Limited
• 16. Wexler Surgical, Inc.